Covid 19: How harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine.

Autor: Horel S; Paris, France horel@lemonde.fr., Keyzer T; Amsterdam, Netherlands.
Jazyk: angličtina
Zdroj: BMJ (Clinical research ed.) [BMJ] 2021 Jun 02; Vol. 373, pp. n1303. Date of Electronic Publication: 2021 Jun 02.
DOI: 10.1136/bmj.n1303
Abstrakt: Competing Interests: Competing interests: Stéphane Horel is a staff member at Le Monde. Harry Karanikas, Ties Keyzer, and Eva Schram worked on this research on a freelance basis for The Investigative Desk. The Desk funds its work with donations, structural subsidies, grants, project related subsidies, and publication fees. This project was partially funded by the KWF Dutch Cancer Society. The Desk is fully independent in the selection, investigation, and publication of our topics. Donors have no role or substantive say in this, and we do not align the timing of our publications with them. For an overview of our partners, financial statements, and reports, see https://investigativedesk.com/about/.
Databáze: MEDLINE